Cision PR Newswire

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...

Navi Medical Technologies’ Neonav® ECG Tip Location System Receives FDA 510(k) Clearance

Revolutionising Vascular Access Care for Critically Ill Newborns and Children Key Points: FDA 510(k) Clearance Neonav® ECG Tip Location System...

SCIA boosts global ventures of Chinese enterprises

BEIJING, Feb. 15, 2025 /PRNewswire/ -- A news report from chinadaily.com.cn: View of 2025 SCIA Spring Reception....

HYPTEC HT Tops the Best-selling List of High-end Pure Electric SUV in Thailand for Two Consecutive Months

BEIJING, Feb. 15, 2025 /PRNewswire/ -- The latest monthly sales data from Thailand show that HYPTEC HT, a premium model from the Chinese EV brand...

Shawn “JAY-Z” Carter Issues Statement After Jane Doe Lawsuit Regarding False Rape Allegations Gets Dismissed With Prejudice

NEW YORK, Feb. 15, 2025 /PRNewswire/ -- Today, Shawn "JAY-Z" Carter issued the below statement in response to the dismissal of Tony Buzbee's Jane Doe...